Literature DB >> 2741856

Risk factors for infant botulism in the United States.

J S Spika1, N Shaffer, N Hargrett-Bean, S Collin, K L MacDonald, P A Blake.   

Abstract

To define risk factors for infant botulism, we performed a 2-year prospective case-control study of 68 laboratory-confirmed cases in infants living in the United States, outside of California. For each case patient, two control subjects were matched by date and hospital of birth or county birth records. By univariate analysis, breast-feeding (odds ratio = 2.9) and consumption of honey (odds ratio = 9.8) were associated with disease, but only 11 case patients (16%) had eaten honey. Decreased frequency of bowel movement (less than one per day for at least 2 months) was also associated with disease in infants 2 months of age and older (odds ratio = 5.2). Risk factors changed with the age of the patient at disease onset when analyzed by multivariate logistic regression methods. For infants less than 2 months old, living in a rural area or on a farm was the only significant risk factor (odds ratio = 6.4). For infants 2 months of age and older, breast-feeding (odds ratio = 3.8), less than one bowel movement per day for at least 2 months (odds ratio = 2.9), and ingestion of corn syrup (odds ratio = 5.2) were associated with disease. The severity of the disease was similar for breast- and bottle-fed infants. Clearly defined food exposures account for a minority of infant botulism cases. Preexisting host factors, such as intestinal flora and frequency of bowel movements, may be the most important risk factors for development of disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2741856     DOI: 10.1001/archpedi.1989.02150190078026

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  9 in total

Review 1.  Clostridial neurotoxins.

Authors:  A Goonetilleke; J B Harris
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-09       Impact factor: 10.154

Review 2.  Update: infant botulism.

Authors:  T F Midura
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

3.  Food-borne illnesses during pregnancy: prevention and treatment.

Authors:  Carolyn Tam; Aida Erebara; Adrienne Einarson
Journal:  Can Fam Physician       Date:  2010-04       Impact factor: 3.275

4.  Equine botulinum antitoxin for the treatment of infant botulism.

Authors:  Elida E Vanella de Cuetos; Rafael A Fernandez; María I Bianco; Omar J Sartori; María L Piovano; Carolina Lúquez; Laura I T de Jong
Journal:  Clin Vaccine Immunol       Date:  2011-09-14

5.  A summary of surveillance, morbidity and microbiology of laboratory-confirmed cases of infant botulism in Canada, 1979-2019.

Authors:  Richard Harris; Christine Tchao; Natalie Prystajecky; Jennifer Cutler; John W Austin
Journal:  Can Commun Dis Rep       Date:  2021-06-08

6.  Infant botulism: a rare cause of colonic ileus.

Authors:  S V Kothare; E G Kassner
Journal:  Pediatr Radiol       Date:  1995

7.  First confirmed case of infant botulism caused by Clostridium botulinum type A(B) in a 10-month-old infant in Hanoi, Vietnam.

Authors:  Tang Thi Nga; Le Huy Hoang; Le Thi Trang; Nguyen Thuy Tram; Pham Bao Yen; Nguyen Thanh Trung; Nguyen Thi Huong Giang; Dang Thi Thuy Duong; Ta Anh Tuan; Bui Thi Tho; Masatomo Morita; Tsuyoshi Kenri; Mitsutoshi Senoh
Journal:  IJID Reg       Date:  2022-08-18

8.  Infant botulism due to C. butyricum type E toxin: a novel environmental association with pet terrapins.

Authors:  E B Shelley; D O'Rourke; K Grant; E McArdle; L Capra; A Clarke; E McNamara; R Cunney; P McKeown; C F L Amar; C Cosgrove; M Fitzgerald; P Harrington; P Garvey; F Grainger; J Griffin; B J Lynch; G McGrane; J Murphy; N Ni Shuibhne; J Prosser
Journal:  Epidemiol Infect       Date:  2014-10-13       Impact factor: 4.434

9.  Characterizing the fecal microbiota of infants with botulism.

Authors:  T Brian Shirey; Janet K Dykes; Carolina Lúquez; Susan E Maslanka; Brian H Raphael
Journal:  Microbiome       Date:  2015-11-23       Impact factor: 14.650

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.